SUPN - Shares of Supernus Pharmaceuticals Inc. (SUPN) Have Risen Above Previous 52-Week High
Shares of Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) traded at a new 52-week high today of $32.01. This new high was reached on below average trading volume as 366,000 shares traded hands, while the average 30-day volume is approximately 699,000 shares.
Based on a current price of $31.92, Supernus Pharmaceuticals Inc. is currently 12.0% above its average consensus analyst price target of $28.08.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others.
Supernus Pharmaceuticals Inc. share prices have moved between a 52-week high of $32.01 and a 52-week low of $17.20 and are now trading 86% above that low price at $31.92 per share.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer